Skip to content
Category: Investor News
Vaneltix enters joint development agreement with Hyloris Pharmaceuticals
December 21, 2021
On Thursday, December 16, Vaneltix entered into a Joint Development Agreement with Hyloris Pharmaceuticals NV, a Belgian pharmaceuticals company (“Hyloris”)…
Closing of shareholder offering
November 25, 2020
Vaneltix announces the results of the 2020 Stockholder Offering and Bridge Loan Conversion: The company raised additional proceeds of $900,000…
Vaneltix Pharma, Inc.
317 George St., Ste. 400,
New Brunswick, NJ 08901
2021 © Vaneltix. All rights reserved.
This website is created by